Home / Medical devices / Cre8 Carbostent
Cre8 Carbostent
 |
Max. value paid with public resources: Processing |
 |
Data for med. device |
| 07IIIC3417922734 |
| 07/02/2014 10:25 |
| 07/02/2014 10:31 |
| 06/02/2014 13:23 |
 | Identification of the manufacturer |
| CID S.P.A. |
| CID |
| Other |
| VAT |
| IT06356990967 |
| IT |
| SALUGGIA |
| 13040 |
| STRADA CRESCENTINO |
| EDOARDO TRONCHET |
| +39 0161 18 26 1 |
| edoardo.tronchet@cidvascular.com |
 | Identification of the person placing the product on the market |
| DEVIMED LTD |
| EIK |
| 130322047 |
| BG |
| SOF |
| Sofia |
| 34 Nikolai Liliev |
| Aleksandar Madzharov |
| +35929533616 |
| devimed@abv.bg |
 | Identification of the wholesaler |
| DEVIMED LTD |
| EIK |
| 130322047 |
| BG |
| SOF |
| Sofia |
| 34 Nikolai Liliev |
| Aleksandar Madzharov |
| +35929533616 |
| devimed@abv.bg |
| IV-P-T/МИ - 180 |
| 10/12/2007 |
 | General medical information about the device |
| 07 - Non-active implantable devices |
| Class ІІІ |
| Cardiovascular system |
| GMDN |
| 34179 |
| STENT, VASCULAR+DELIVERY SYSTEM, DRUG |
| Cre8 Carbostent |
 | Description of the medical device |
| Sterility |
 | Intended action by the manufacturer |
| The Cre8 Carbostent is intended for the treatment of stenotic lesions in coronary arteries and coronary artery bypasses to maintain vessel patency. |
| Single use |
 | General trade information |
| Processing |
| 201107130341012-1013-1014CT |
| 31/03/2014 |
